868601-06-3

Upstream product

• 64-17-5 ethanol 
• 76883-63-1 N-(3-acetylphenyl)benzenesulfonamide 

Downstream Products

• 935847-54-4 ethyl 1-{3-[2-(3-benzenesuphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazo[4,5-c]pyridine-6-carboxylate 
• 935847-61-3 ethyl 3-{3-[2-(3-benzenesulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-3H-imidazo[4,5-c]pyridine-6-carboxylate 
• 935847-75-9 methyl 1-{3-[2-(3-benzenesulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazo[4,5-b]pyridine-5-carboxylate 
• 935872-98-3 N-(3-{2-[1,1-dimethyl-3-(6-nitro-benzimidazol-1-yl)-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide 

Relevant academic research and scientific papers

Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs

Compounds of the formula which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: ethyl 3-{3-[(R)-2-(3-benzenesulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-3H-imidazo[4,5-b]p

Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments

Compounds of general formula (I) which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: [4-(1-{3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)

Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in ths claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R7 have the meanings given in the claims and specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof, t

NOVEL BETA AGONISTS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS

The invention relates to the novel beta agonists of general formula (I); wherein the groups R1 to R7 are defined as in the claims and the description, and to the tautomers, enantiomers, diastereomers, mixtures, prodrugs and salts the